BPS News | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.

All posts in BPS News

Ratmir Derda receives the Young Investigator Award

July 8, 2014 (Boulder, CO)  -   Ratmir DerdaThe Boulder Peptide Society is pleased to announce that Dr Ratmir Derda, at the University of Alberta,  has received the Young Investigator Award for 2014.  The Young Investigator Award was established earlier in the year to support promising peptide scientists during the pre-tenure period. 

Ratmir Derda is the Assistant Professor in Department of Chemistry at University of Alberta. Ratmir received his B.Sci. in Physics and Biophysics from Moscow Institute of Physics and Technology in 2001 and Ph.D. in Chemistry from the University of Wisconsin-Madison in 2008, under the supervision of Laura L. Kiessling. From 2008 to 2011, he was a postdoctoral researcher at Harvard University working under the supervision of George M. Whitesides at the Department of Chemistry and Chemical Biology and Donald E. Ingber, at the Wyss Institute for Biologically Inspired Engineering

.

Ratmir is an emerging star who combines a solid background in biology, cutting edge knowledge of technology and microfluidics with chemical insights. He has authored 32 publications in the areas of chemical biology, peptide chemistry and peptide discovery for cell growth and differentiation studies. Of the 32, publications, 15 were published during the first three years of independent career, and four of these publications were featured on the journal covers (ACS Chemical Biology, Lab on a Chip and Angewandte Chemie). He is editor in Peptide Libraries book (Springer Methods in Molecular Biology Series); the book is undergoing last stages of the assembly process.  He is an author on seven patent applications and one published patent (peptide arrays for discovery of sequences that control stem cell differentiation); the latter technology has been licensed to Cellular Dynamics International Inc. Technology developed in his post-graduate research is used as a core platform in a startup company in Boston, MA (CellBridge LLC). In his independent group, he has established an distribution service Syntarray, which will provide samples of patterned planar support for peptide synthesis and cell biology applications. 

In his independent career, Ratmir Derda raised over 2M in funding, which originate from Canadian federal and provincial sources as well as a US peptide pharmaceutical company (Ferring Pharmaceuticals). In 2011, he was a recipient of Rising Star in Global Health Award from Grand Challenges Canada in 2011 and he used the funds provided by the award to organize the first conference and hands-on demonstration of prototypes of diagnostic devices in Nairobi, Kenya. Ratmir has also established a track record of mentoring and supporting junior investigators in his laboratory. For these achievements, he was recently selected for a student-nominated Award for Outstanding Mentorship in Undergraduate Research from the University of Alberta. 


In recognition of the professional and scientific achievements,  the Scientific Advisory Board of the Boulder Peptide Society is pleased to present the award to Ratmir Derda. Dr Derda shall also present an oral presentation on his research and formally accept the award at the fall Boulder Peptide Symposium Sept 22-24 in Boulder, Colorado.

For more information visit www.boulderpeptide.org

 

Bill Lambert from Medimmune Joins the BPS Scientific Advisory Board

The Scientific Advisory Board of the Boulder Peptide Society is pleased to add William Lambert, Ph.D. to help craft the scientific session of the 2014 Boulder Peptide Symposium.

Bill brings a wealth of pharmaceutical development leadership experience through
the formulation and delivery technology roles he has held at both pharmaceutical and delivery companies such as Pfizer, Eisai, and Pacira Pharmaceuticals.  He is currently Fellow and Head of the Innovative Drug Delivery Group at MedImmune / AstraZeneca in Gaithersburg, MD.  Bill has a Ph.D. From the University of Utah.

Welcome to our team Bill !

Boulder Peptide Society Establishes the Young Investigator Award

January 31, 2014 (Boulder, CO) - The Boulder Peptide Society is pleased to announce it is establishing the Boulder
Peptide Young Investigator Award as a new award to be given to a young academic investigator with great potential for scientific contributions to the field of peptide chemistry, formulation, delivery, and analytical characterization.

Boulder Peptide Society prides itself on supporting pioneering science in the peptide field and this award is a way to bring young investigators to the meeting to meet colleagues, potential collaborators, and companies with interest in new technologies.

The award recipient will speak at the Boulder Peptide Symposium on September 22, 2014.  The award winner will receive an honorarium in addition to paid travel, hotel, and registration, which will be covered by the Boulder Peptide Society.

Boulder Peptide Society Announces New SAB and 2014 Meeting

Boulder, CO, November 23, 2013 --(PR.com)-- The Boulder Peptide Symposium will host its 8th Annual meeting in late September 2014. In preparation, the symposium board of trustees has assembled an esteemed Scientific Advisory Board to foster the event. The SAB brings together experts from industry and academia with a significant body of experience in discovery and development of peptide therapeutics.

John Carpenter, Ph.D.
Professor of Pharmaceutical Sciences and Co-Director of the Center for Pharmaceutical Biotechnology, University of Colorado, Anschutz Medical Campus, Denver
 
Waleed Danho, Ph.D.
Consultant, formerly Distinguished Research Leader, Hoffmann La Roche
 
Phil Dawson, Ph.D.
Associate Professor & Associate Dean of Graduate Studies, The Scripps Research Institute, La Jolla
 
Nader Fotouhi, Ph.D.
Vice President, Pharma Research and Early Development Site Leader, Hoffmann La Roche, Nutley
 
Tomas Landh, Ph.D.
Director of Strategy and Innovation Sourcing, Novo Nordisk, Denmark
 
Barbara Lueckel, Ph.D.
Global Business Development Director, F. Hoffman-La Roche Ltd., Basel
 
John Mayer, Ph.D.
Senior Research Scientist, University of Indiana
 
Chris Rhodes, Ph.D.
Consultant in Pharmaceutical Technology, formerly Executive Director, Pharmaceutical R&D, Amylin Pharmaceuticals
 
Tomi Sawyer, Ph.D.
Entrepreneurial Drug Hunter, Adjunct Professor, University of Massachusetts and UMass Medical School, formerly Chief Scientific Officer, Aileron Therapeutics
 
Ved Srivastava, Ph.D.
Head, Peptide Chemistry, GlaxoSmithKline
 
Elizabeth Topp, Ph.D.
Dane O. Kildsig Chair and Head of the Department of Industrial and Physical Pharmacy, Purdue University

Each year, the Boulder Peptide Symposium is organized around a theme. The SAB has designed a meeting for 2014 that will be focused broadly on peptides in infectious disease, including anti-virals, anti-microbials, and neglected diseases. Special emphasis will be given to platform technologies designed to create constrained peptide structures with improved properties.

The Boulder Peptide Symposium is a nonprofit organization. More information about the mission and the annual meeting can be found on the website at www.boulderpeptide.org.

The 8th Annual meeting will take place at the St. Julien Hotel and Spa in Boulder Colorado on Sept 22 to 24, 2014.

Read the full press release on www.pr.com

New Speaker Alert: Dr Laurie Parker, of Purdue University

Dr Laurie shall be presenting on the application of peptides as biosensors to monitor intracellular signalling pathways. Check the BPS website soon for an abstract.


s2Member®
loading...